IN2014MN01800A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01800A
IN2014MN01800A IN1800MUN2014A IN2014MN01800A IN 2014MN01800 A IN2014MN01800 A IN 2014MN01800A IN 1800MUN2014 A IN1800MUN2014 A IN 1800MUN2014A IN 2014MN01800 A IN2014MN01800 A IN 2014MN01800A
Authority
IN
India
Prior art keywords
nanoparticles
methods
interaction
measuring
present
Prior art date
Application number
Other languages
English (en)
Inventor
Meike Roskamp
Vanessa Bonnard
Sylviane Boucharens
Original Assignee
Pharmadiagnostics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmadiagnostics Nv filed Critical Pharmadiagnostics Nv
Publication of IN2014MN01800A publication Critical patent/IN2014MN01800A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Materials Engineering (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN1800MUN2014 2012-02-16 2013-02-15 IN2014MN01800A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261599455P 2012-02-16 2012-02-16
GBGB1202631.6A GB201202631D0 (en) 2012-02-16 2012-02-16 Method of measuring interaction between molecules
PCT/EP2013/053103 WO2013121011A1 (fr) 2012-02-16 2013-02-15 Procédé et trousse pour la mesure de l'interaction entre des molécules

Publications (1)

Publication Number Publication Date
IN2014MN01800A true IN2014MN01800A (fr) 2015-07-03

Family

ID=45939693

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1800MUN2014 IN2014MN01800A (fr) 2012-02-16 2013-02-15

Country Status (9)

Country Link
US (2) US9678066B2 (fr)
EP (1) EP2814774A1 (fr)
AU (1) AU2013220314B2 (fr)
BE (1) BE1020732A5 (fr)
CA (1) CA2864614A1 (fr)
GB (1) GB201202631D0 (fr)
HK (1) HK1203919A1 (fr)
IN (1) IN2014MN01800A (fr)
WO (1) WO2013121011A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016057474A1 (fr) * 2014-10-06 2016-04-14 Indiana University Research & Technology Corporation Systèmes et procédés de biodétection par résonance plasmonique de surface localisée
CA2989056C (fr) * 2015-06-30 2020-12-01 Imec Vzw Immobilisation en surface d'une molecule de reconnaissance d'analyte
CL2017001945A1 (es) * 2017-07-30 2018-10-19 Univ Tecnica Federico Santa Maria Utfsm Método, proceso, composición y kit para medir concentración de moléculas disueltas en la fase continua de un coloide.
US10758983B1 (en) 2018-04-17 2020-09-01 Government Of The United States, As Represented By The Secretary Of The Air Force Concentrated synthesis of monodispersed gold nanorods
CL2018001473A1 (es) * 2018-06-01 2019-10-25 Univ Tecnica Federico Santa Maria Utfsm Kit y métodos para evaluar las propiedades adsorbentes de la superficie de un material
US12163183B2 (en) 2018-10-22 2024-12-10 Indiana University Research And Technology Corporation Systems and methods for localized surface plasmon resonance biosensing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275310A1 (en) 2004-09-30 2006-12-07 Nano Science Diagnostics, Inc. Method and detection and decontamination of antigens by nanoparticle-raman spectroscopy
US8426152B2 (en) 2007-01-03 2013-04-23 Lamdagen Corporation Enzymatic assay for LSPR
CA2685450A1 (fr) 2007-05-29 2009-03-12 Pharma Diagnostics Nv Reactifs et procedes de determination des caracteristiques pk/adme-tox d'entites chimiques inedites et de candidats medicaments
US20120164073A1 (en) 2007-11-30 2012-06-28 Old Dominion University Stable nanoparticles, nanoparticle-based imaging systems, nanoparticle-based assays, and in vivo assays for screening biocompatibility and toxicity of nanoparticles
WO2010029175A1 (fr) * 2008-09-12 2010-03-18 Modpro Ab Procédé et dispositif de détection sur la base de l’agrégation de nanoparticules
GB201003088D0 (en) 2010-02-24 2010-04-14 Univ Exeter Method for the preparation of a novel nanoparticle conjugate

Also Published As

Publication number Publication date
US20170248589A1 (en) 2017-08-31
BE1020732A5 (nl) 2014-04-01
US20150024402A1 (en) 2015-01-22
GB201202631D0 (en) 2012-04-04
HK1203919A1 (en) 2015-11-06
CA2864614A1 (fr) 2013-08-22
AU2013220314B2 (en) 2016-03-10
US9678066B2 (en) 2017-06-13
AU2013220314A1 (en) 2014-08-14
EP2814774A1 (fr) 2014-12-24
WO2013121011A1 (fr) 2013-08-22

Similar Documents

Publication Publication Date Title
NZ799532A (en) Methods and means for the production of ig-like molecules
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
CY1123550T1 (el) Διπλοειδικα egfr/c-met αντισωματα
AU2017204797B2 (en) Antibodies with modified isoelectric points
CR20130359A (es) Anticuerpos del cea
SA112330988B1 (ar) أجسام مضادة تخص trop-2 واستخداماتها
UA114707C2 (uk) БІСПЕЦИФІЧНА ЗВ'ЯЗУВАЛЬНА МОЛЕКУЛА, ЯКА ЗВ'ЯЗУЄТЬСЯ З VEGF I Ang2
MX2014012978A (es) Regiones de anticuerpo modificado y sus usos.
MX2016008098A (es) Anticuerpos biespecificos del receptor 2 de factor de crecimiento ipidermico himano (her2) y metodo de uso.
BR112015024553A2 (pt) anticorpo multiespecífico, anticorpo isolado, ácido nucleico isolado, célula hospedeira, método de produção de anticorpo, imunoconjugado, formulação farmacêutica, uso de anticorpo e método de tratamento de indivíduos com distúrbio
EA201490768A1 (ru) Применение молекул, связывающих семафорин-4d, для модуляции проницаемости гематоэнцефалического барьера
MX2015012122A (es) Conjugados de anticuerpo-farmaco y los anticuerpos correspondientes.
MX2014015088A (es) Anticuerpos anti-tofacitinib y usos de los mismos para monitorear farmacos.
IN2014MN01800A (fr)
ECSP14028523A (es) Moléculas de anticuerpo anti-gcc y uso de las mismas
UA110470C2 (ru) Антидот антикоагулянта
MX342034B (es) Proteinas monovalentes que se unen a antigenos.
EA201590173A1 (ru) Иммуноконъюгаты, содержащие антитела к cd22
UA118083C2 (uk) ВИДІЛЕНЕ МОНОКЛОНАЛЬНЕ АНТИТІЛО ПРОТИ МОЛЕКУЛИ ВІДШТОВХУВАЛЬНОГО НАПРЯМНОГО СИГНАЛУ (RGMa) ТА ЙОГО ЗАСТОСУВАННЯ В ЛІКУВАННІ РОЗЛАДУ, АСОЦІЙОВАНОГО З ДЕГЕНЕРАЦІЄЮ НЕЙРИТІВ
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
WO2014100143A3 (fr) Formulation d'anticorps liquide ayant des propriétés d'agrégation améliorées
BR112014002140A2 (pt) anticorpo anti-cxcr4 e uso do mesmo para a detecção e o diagnóstico de câncer
TN2013000388A1 (en) Anticoagulant antidotes
GB2495884A (en) A method of increasing the effect of an activated-potentiated form of an antibody
WO2012060882A3 (fr) Détection interférométrique à l'aide de nanoparticules